April 2019
“ POST-OPERATIVE PERIAPICAL PATHOLOGY AROUND DENTAL IMPLANTS” -a new article by Randolph Resnik, DMD, MDS
March 2019
“The Vulnerability of Dental Practices to Cyber Attacks?” -a new article by Gary Salman & Paul Murphy
January 2019
THE MISCH INSTITUTE NEWSLETTER UPCOMING EVENTS SURGICAL SESSIONS 1 – 5 Rosen Shingle Creek Resort Orlando , Florida Session 1 Patient Evaluation, Treatment Planning, & Implant Placement into Abundant Bone February 8-9, 2019 Session 2 Treatment of the Edentulous Arch March 29-30, 2019 Session 3 Implant Placement & Bone Augmentation into Compromised Sites May 17-18,…
August 2018
THE MISCH INSTITUTE NEWSLETTER IN MEMORIUM It is with heavy hearts today that we say farewell to one of our close Resnik Implant Institute family members, Dr. Michael D. Ginder of Athens, Ohio. He was a Misch graduate and a favorite of the faculty and staff. He not only was an excellent clinician, he was…
July 2018
THE MISCH INSTITUTE NEWSLETTER New Prophylactic Antibiotic Protocol for Sinus Graft Procedures For years, Augmentin (Amoxicillin-clavulanate) has been used as the first line antibiotic for the therapeutic and prophylactic treatment of sinus graft procedures because of its superior beta-lactamase coverage. With Penicillin allergy patients, the use of Fluoroquinolones (Levaquin, Avelox) were popular as alternative medications.…
June 2018
THE MISCH INSTITUTE NEWSLETTER Beware of the Complications of a New Drug Class: The “Biologics” A new class of therapeutic drugs are becoming more popular in the treatment of an array of medical conditions such as autoimmune disease and cancers. These new drugs are termed “Biologics”. Biologics use living organisms (genes) and are manufactured by…